Clinical Indicators for Coders/CDI The following clinical findings in the medical record should prompt coders and CDI specialists to query for additional specificity or linkage of diabetes complications
L-Carnitine is non-hormonal and safe for women
The origin of the problem lies in impaired redox homeostasis, which causes damage to cell membrane, compromising the viability and integrity of the central nervous system (CNS) (Van Horssen et al., 2011
The mammalian target of rapamycin (mTOR) integrates nutrient availability, energy status and growth factor signals to regulate protein synthesis
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained significant attention for weight management beyond its original diabetes indication
For assessing the safety and pharmacokinetics of oral semaglutide in healthy subjects and subjects with type 2 diabetes, the drug was measured in plasma after protein precipitation using LC-MS/MS with a lower Limit of quantification of 0.73 nmol/L [80]